David Tischler

David Tischler has diverse work experience in the biotechnology and healthcare industry. David has worked as the CEO and co-founder of ZetaGen Therapeutics, where they led the strategy, financing, and operations of the company. David also served as the CEO (Interim) of Verana Health, a digital health company focused on ophthalmic disease progression monitoring. Additionally, Tischler worked as a Product Manager at Castlight Health, where they played a key role in developing innovative healthcare decision-making tools. David has also held roles as a Research Scientist at the University of California, Los Angeles, and as an Associate at Venzyme Venture Catalyst. In recent years, Tischler has been engaged by various venture capital firms and their portfolio companies as a business advisor, providing expertise in financing, business development, corporate development, and product management. David has worked with companies in various areas such as biologics, gene therapy, artificial intelligence, and digital health, with a focus on immunology, rare disease, and oncology. Tischler's experience showcases their expertise in the biotech industry and their ability to drive innovation and strategic growth in the companies they have worked with.

David Tischler's education history begins with a Bachelor of Science (BS) degree in Biology from the University of Michigan. Following that, they pursued a Master of Business Administration (M.B.A.) at the Haas School of Business, University of California, Berkeley. David also has attended Stanford University for a degree named SIGM, although the specific details of this degree are not provided. In terms of additional certifications, David has obtained a certification in Data Science for Executives from the University of California, Berkeley in May 2019, and a Pragmatic Marketing Certified - Level Two (PMC-II) in December 2015, although the institution for the latter is not specified.